Trials / Completed
CompletedNCT00185887
Nitroglycerin Versus Terbutaline for Intrapartum Fetal Resuscitation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 110 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To compare nitroglycerin and terbutaline for intrapartum fetal heart rate resuscitation
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Terbutaline | Terbutaline 250 micrograms intravenously for intrapartum fetal resuscitation. Nitroglycerine 400 micrograms intravenously for intrapartum fetal resuscitation. |
Timeline
- Start date
- 2003-10-01
- Primary completion
- 2006-07-01
- Completion
- 2007-10-01
- First posted
- 2005-09-16
- Last updated
- 2011-03-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00185887. Inclusion in this directory is not an endorsement.